Abstract
Pseudomonas aeruginosa is classified as an opportunistic pathogen that causes a wide range of infections in humans, involving nearly all body systems, that vary from local to systemic and from self-limiting to life-threatening. This chapter outlines the features that have made P. aeruginosa a human pathogen. Each section starts with the argument in the heading followed by the epidemiological and/or experimental supportive evidence.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Notes
- 1.
Goethe impishly crafted these contrasting characters with subtle irony: Faust, the ingenious, restless, but desperate Renaissance polymath, and Wagner, a honest, but rather simple-minded scholar, hungry for knowledge.
References
Alvarez-Ortega C, Wiegand I, Olivares J, Hancock RE, Martínez JL (2010) Genetic determinants involved in the susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics. Antimicrob Agents Chemother 54(10):4159–4167. https://doi.org/10.1128/AAC.00257-10
Aoi Y, Nakata H, Kida H (2000) Isolation of Pseudomonas aeruginosa from Ushubetsu River water in Hokkaido, Japan. Jpn J Vet Res 48:29–34
Audenaert K, Pattery T, Cornelis P, Höfte M (2002) Induction of systemic resistance to Botrytis cinerea in tomato by Pseudomonas aeruginosa 7NSK2: role of salicylic acid, pyochelin, and pyocyanin. Mol Plant Microbe Interact 15(11):1147–1156. https://doi.org/10.1094/MPMI.2002.15.11.1147
Balasubramanian D, Schneper L, Kumari H, Mathee K (2013) A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res 41(1):1–20. https://doi.org/10.1093/nar/gks1039
Bartell JA, Cameron DR, Mojsoska B, Haagensen JAJ, Pressler T, Sommer LM, Lewis K, Molin S, Johansen HK (2020) Bacterial persisters in long-term infection: Emergence and fitness in a complex host environment. PLoS Pathog 16(12):e1009112. https://doi.org/10.1371/journal.ppat.1009112
Bédard E, Prévost M, Déziel E (2016) Pseudomonas aeruginosa in premise plumbing of large buildings. Microbiologyopen 5(6):937–956. https://doi.org/10.1002/mbo3.391
Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, Burgel PR, Tullis E, Castaños C, Castellani C, Byrnes CA, Cathcart F, Chotirmall SH, Cosgriff R, Eichler I, Fajac I, Goss CH, Drevinek P, Farrell PM, Gravelle AM, Havermans T, Mayer-Hamblett N, Kashirskaya N, Kerem E, Mathew JL, McKone EF, Naehrlich L, Nasr SZ, Oates GR, O’Neill C, Pypops U, Raraigh KS, Rowe SM, Southern KW, Sivam S, Stephenson AL, Zampoli M, Ratjen F (2020) The future of cystic fibrosis care: a global perspective. Lancet Respir Med 8(1):65–124. https://doi.org/10.1016/S2213-2600(19)30337-6
Bertrand Q, Job V, Maillard AP, Imbert L, Teulon JM, Favier A, Pellequer JL, Huber P, Attrée I, Dessen A (2020) Exolysin (ExlA) from Pseudomonas aeruginosa punctures holes into target membranes using a molten globule domain. J Mol Biol 432(16):4466–4480. https://doi.org/10.1016/j.jmb.2020.05.025
Bielecki P, Komor U, Bielecka A, Müsken M, Puchałka J, Pletz MW, Ballmann M, Martins dos Santos VA, Weiss S, Häussler S (2013) Ex vivo transcriptional profiling reveals a common set of genes important for the adaptation of Pseudomonas aeruginosa to chronically infected host sites. Environ Microbiol 15(2):570–587. https://doi.org/10.1111/1462-2920.12024
Bosshammer J, Fiedler B, Gudowius P, von der Hardt H, Römling U, Tümmler B (1995) Comparative hygienic surveillance of contamination with pseudomonads in a cystic fibrosis ward over a 4-year period. J Hosp Infect 31(4):261–274. https://doi.org/10.1016/0195-6701(95)90205-8
Bragonzi A, Paroni M, Nonis A, Cramer N, Montanari S, Rejman J, Di Serio C, Döring G, Tümmler B (2009) Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am J Respir Crit Care Med 180(2):138–145. https://doi.org/10.1164/rccm.200812-1943OC
Breathnach AS, Cubbon MD, Karunaharan RN, Pope CF, Planche TD (2012) Multidrug-resistant Pseudomonas aeruginosa outbreaks in two hospitals: association with contaminated hospital waste-water systems. J Hosp Infect 82(1):19–24. https://doi.org/10.1016/j.jhin.2012.06.007
Breidenstein EB, Khaira BK, Wiegand I, Overhage J, Hancock RE (2008) Complex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibility. Antimicrob Agents Chemother 52(12):4486–4491. https://doi.org/10.1128/AAC.00222-08
Camus L, Vandenesch F, Moreau K (2021) From genotype to phenotype: adaptations of Pseudomonas aeruginosa to the cystic fibrosis environment. Microb Genom 7(3):mgen000513. https://doi.org/10.1099/mgen.0.000513
Chandler CE, Horspool AM, Hill PJ, Wozniak DJ, Schertzer JW, Rasko DA, Ernst RK (2018) Genomic and phenotypic diversity among ten laboratory isolates of Pseudomonas aeruginosa PAO1. J Bacteriol 201:e00595-18
Chatterjee P, Sass G, Swietnicki W, Stevens DA (2020) Review of potential Pseudomonas weaponry, relevant to the Pseudomonas-Aspergillus interplay, for the Mycology Community. J Fungi (Basel) 6(2):81. https://doi.org/10.3390/jof6020081
Conrad D, Haynes M, Salamon P, Rainey PB, Youle M, Rohwer F (2013) Cystic fibrosis therapy: a community ecology perspective. Am J Respir Cell Mol Biol 48(2):150–156. https://doi.org/10.1165/rcmb.2012-0059PS
Conrad DJ, Billings J, Teneback C, Koff J, Rosenbluth D, Bailey BA, Jain R (2021) Multi-dimensional clinical phenoty** of a national cohort of adult cystic fibrosis patients. J Cyst Fibros 20(1):91–96. https://doi.org/10.1016/j.jcf.2020.08.010
Cottalorda A, Leoz M, Dahyot S, Gravey F, Grand M, Froidure T, Aujoulat F, Le Hello S, Jumas-Bilak E, Pestel-Caron M (2021) Within-host microevolution of Pseudomonas aeruginosa urinary isolates: A seven-patient longitudinal genomic and phenotypic study. Front Microbiol 11:611246. https://doi.org/10.3389/fmicb.2020.611246
Cramer N, Klockgether J, Wrasman K, Schmidt M, Davenport CF, Tümmler B (2011) Microevolution of the major common Pseudomonas aeruginosa clones C and PA14 in cystic fibrosis lungs. Environ Microbiol 13(7):1690–1704. https://doi.org/10.1111/j.1462-2920.2011.02483.x
Davies EV, James CE, Kukavica-Ibrulj I, Levesque RC, Brockhurst MA, Winstanley C (2016) Temperate phages enhance pathogen fitness in chronic lung infection. ISME J 10(10):2553–2555. https://doi.org/10.1038/ismej.2016.51
Davis TJ, Karanjia AV, Bhebhe CN, West SB, Richardson M, Bean HD (2020) Pseudomonas aeruginosa volatilome characteristics and adaptations in chronic cystic fibrosis lung infections. mSphere 5(5):e00843–e00820. https://doi.org/10.1128/mSphere.00843-20
Del Barrio-Tofiño E, Zamorano L, Cortes-Lara S, López-Causapé C, Sánchez-Diener I, Cabot G, Bou G, Martínez-Martínez L, Oliver A, GEMARA-SEIMC/REIPI Pseudomonas Study Group (2019) Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology. J Antimicrob Chemother 74(7):1825–1835. https://doi.org/10.1093/jac/dkz147
de Lorenzo V (2014) From the selfish gene to selfish metabolism: revisiting the central dogma. Bioessays 36(3):226–235. https://doi.org/10.1002/bies.201300153
de Lorenzo V (2015) Pseudomonas aeruginosa: the making of a pathogen. Environ Microbiol 17(1):1–3. https://doi.org/10.1111/1462-2920.12620
Depke T, Thöming JG, Kordes A, Häussler S, Brönstrup M (2020) Untargeted LC-MS metabolomics differentiates between virulent and avirulent clinical strains of Pseudomonas aeruginosa. Biomolecules 10(7):1041. https://doi.org/10.3390/biom10071041
Döring G, Ulrich M, Müller W, Bitzer J, Schmidt-Koenig L, Münst L, Grupp H, Wolz C, Stern M, Botzenhart K (1991) Generation of Pseudomonas aeruginosa aerosols during handwashing from contaminated sink drains, transmission to hands of hospital personnel, and its prevention by use of a new heating device. Zentralbl Hyg Umweltmed 191(5-6):494–505
Dötsch A, Eckweiler D, Schniederjans M, Zimmermann A, Jensen V, Scharfe M, Geffers R, Häussler S (2012) The Pseudomonas aeruginosa transcriptome in planktonic cultures and static biofilms using RNA sequencing. PLoS One 7(2):e31092. https://doi.org/10.1371/journal.pone.0031092
Eichenberger EM, Thaden JT (2019) Epidemiology and mechanisms of resistance of extensively drug resistant Gram-negative bacteria. Antibiotics (Basel) 8(2):pii: E37
El-Banna T, Abd El-Aziz A, Sonbol F, El-Ekhnawy E (2019) Adaptation of Pseudomonas aeruginosa clinical isolates to benzalkonium chloride retards its growth and enhances biofilm production. Mol Biol Rep 46(3):3437–3443. https://doi.org/10.1007/s11033-019-04806-7
Fajardo A, Martínez-Martín N, Mercadillo M, Galán JC, Ghysels B, Matthijs S, Cornelis P, Wiehlmann L, Tümmler B, Baquero F, Martínez JL (2008) The neglected intrinsic resistome of bacterial pathogens. PLoS One 3(2):e1619. https://doi.org/10.1371/journal.pone.0001619
Feltner JB, Wolter DJ, Pope CE, Groleau MC, Smalley NE, Greenberg EP, Mayer-Hamblett N, Burns J, Déziel E, Hoffman LR, Dandekar AA (2016) LasR variant cystic fibrosis isolates reveal an adaptable quorum-sensing hierarchy in Pseudomonas aeruginosa. MBio 7(5):e01513–e01516. https://doi.org/10.1128/mBio.01513-16
Filloux A, Ramos JL (2014) Pseudomonas methods and protocols. Methods Mol Biol 1149:1–816. https://doi.org/10.1007/978-1-4939-0473-0
Fischer S, Dethlefsen S, Klockgether J, Tümmler B (2020) Phenotypic and genomic comparison of the two most common ExoU-positive Pseudomonas aeruginosa clones, PA14 and ST235. mSystems 5(6):e01007–e01020. https://doi.org/10.1128/mSystems.01007-20
Flynn JM, Niccum D, Dunitz JM, Hunter RC (2016) Evidence and role for bacterial mucin degradation in cystic fibrosis airway disease. PLoS Pathog 12(8):e1005846. https://doi.org/10.1371/journal.ppat.1005846
Flynn JM, Cameron LC, Wiggen TD, Dunitz JM, Harcombe WR, Hunter RC (2020) Disruption of cross-feeding inhibits pathogen growth in the sputa of patients with cystic fibrosis. mSphere 5(2):e00343–e00320. https://doi.org/10.1128/mSphere.00343-20
Foulkes DM, McLean K, Haneef AS, Fernig DG, Winstanley C, Berry N, Kaye SB (2019) Pseudomonas aeruginosa toxin ExoU as a therapeutic target in the treatment of bacterial infections. Microorganisms 7:707
Fourie R, Pohl CH (2019) Beyond antagonism: The interaction between Candida species and Pseudomonas aeruginosa. J Fungi (Basel) 5(2):34. https://doi.org/10.3390/jof5020034
Freschi L, Jeukens J, Kukavica-Ibrulj I, Boyle B, Dupont MJ, Laroche J, Larose S, Maaroufi H, Fothergill JL, Moore M, Winsor GL, Aaron SD, Barbeau J, Bell SC, Burns JL, Camara M, Cantin A, Charette SJ, Dewar K, Déziel É, Grimwood K, Hancock RE, Harrison JJ, Heeb S, Jelsbak L, Jia B, Kenna DT, Kidd TJ, Klockgether J, Lam JS, Lamont IL, Lewenza S, Loman N, Malouin F, Manos J, McArthur AG, McKeown J, Milot J, Naghra H, Nguyen D, Pereira SK, Perron GG, Pirnay JP, Rainey PB, Rousseau S, Santos PM, Stephenson A, Taylor V, Turton JF, Waglechner N, Williams P, Thrane SW, Wright GD, Brinkman FS, Tucker NP, Tümmler B, Winstanley C, Levesque RC (2015) Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium. Front Microbiol 6:1036. https://doi.org/10.3389/fmicb.2015.01036
Freschi L, Vincent AT, Jeukens J, Emond-Rheault JG, Kukavica-Ibrulj I, Dupont MJ, Charette SJ, Boyle B, Levesque RC (2019) The Pseudomonas aeruginosa pan-genome provides new insights on its population structure, horizontal gene transfer, and pathogenicity. Genome Biol Evol 11(1):109–120. https://doi.org/10.1093/gbe/evy259. PMID: 30496396; PMCID: PMC6328365
Frimmersdorf E, Horatzek S, Pelnikevich A, Wiehlmann L, Schomburg D (2010) How Pseudomonas aeruginosa adapts to various environments: a metabolomic approach. Environ Microbiol 12(6):1734–1747. https://doi.org/10.1111/j.1462-2920.2010.02253.x
Gabrielaite M, Johansen HK, Molin S, Nielsen FC, Marvig RL (2020) Gene loss and acquisition in lineages of Pseudomonas aeruginosa evolving in cystic fibrosis patient airways. MBio 11(5):e02359–e02320. https://doi.org/10.1128/mBio.02359-20
Galle M, Carpentier I, Beyaert R (2012) Structure and function of the Type III secretion system of Pseudomonas aeruginosa. Curr Protein Pept Sci 13(8):831–842
Garratt I, Aranega-Bou P, Sutton JM, Moore G, Wand ME (2021) Long-term exposure to octenidine in a simulated sink trap environment results in selection of Pseudomonas aeruginosa, Citrobacter, and Enterobacter isolates with mutations in efflux pump regulators. Appl Environ Microbiol 87(10):e00210–e00221. https://doi.org/10.1128/AEM.00210-21
Gbaguidi-Haore H, Varin A, Cholley P, Thouverez M, Hocquet D, Bertrand X (2018) A bundle of measures to control an outbreak of Pseudomonas aeruginosa associated with P-trap contamination. Infect Control Hosp Epidemiol 39(2):164–169. https://doi.org/10.1017/ice.2017.304
Green SK, Schroth MN, Cho JJ, Kominos SK, Vitanza-jack VB (1974) Agricultural plants and soil as a reservoir for Pseudomonas aeruginosa. Appl Microbiol 28(6):987–991. https://doi.org/10.1128/am.28.6.987-991.1974
Grekov I, Thöming JG, Kordes A, Häussler S (2021) Evolution of Pseudomonas aeruginosa toward higher fitness under standard laboratory conditions. ISME J 15(4):1165–1177. https://doi.org/10.1038/s41396-020-00841-6
Hauser AR (2009) The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol 7:654–665
Hilker R, Munder A, Klockgether J, Losada PM, Chouvarine P, Cramer N, Davenport CF, Dethlefsen S, Fischer S, Peng H, Schönfelder T, Türk O, Wiehlmann L, Wölbeling F, Gulbins E, Goesmann A, Tümmler B (2015) Interclonal gradient of virulence in the Pseudomonas aeruginosa pangenome from disease and environment. Environ Microbiol 17(1):29–46. https://doi.org/10.1111/1462-2920.12606
Hocquet D, Muller A, Bertrand X (2016) What happens in hospitals does not stay in hospitals: antibiotic-resistant bacteria in hospital wastewater systems. J Hosp Infect 93(4):395–402. https://doi.org/10.1016/j.jhin.2016.01.010
Hornischer K, Khaledi A, Pohl S, Schniederjans M, Pezoldt L, Casilag F, Muthukumarasamy U, Bruchmann S, Thöming J, Kordes A, Häussler S (2019) BACTOME-a reference database to explore the sequence- and gene expression-variation landscape of Pseudomonas aeruginosa clinical isolates. Nucleic Acids Res 47(D1):D716–D720. https://doi.org/10.1093/nar/gky895
Howard SA, Furniss RCD, Bonini D, Amin H, Paracuellos P, Zlotkin D, Costa TRD, Levy A, Mavridou DAI, Filloux A (2021) The breadth and molecular basis of Hcp-driven type VI secretion system effector delivery. mBio e0026221. https://doi.org/10.1128/mBio.00262-21
Hwang W, Yong JH, Min KB, Lee KM, Pascoe B, Sheppard SK, Yoon SS (2021) Genome-wide association study of signature genetic alterations among Pseudomonas aeruginosa cystic fibrosis isolates. PLoS Pathog 17(6):e1009681. https://doi.org/10.1371/journal.ppat.1009681
James CE, Davies EV, Fothergill JL, Walshaw MJ, Beale CM, Brockhurst MA, Winstanley C (2015) Lytic activity by temperate phages of Pseudomonas aeruginosa in long-term cystic fibrosis chronic lung infections. ISME J 9(6):1391–1398. https://doi.org/10.1038/ismej.2014.223
Jarvis WR, Martone WJ (1992) Predominant pathogens in hospital infections. J Antimicrob Chemother 29 Suppl A:19–24. https://doi.org/10.1093/jac/29.suppl_a.19
Jernigan JA, Hatfield KM, Wolford H, Nelson RE, Olubajo B, Reddy SC, McCarthy N, Paul P, McDonald LC, Kallen A, Fiore A, Craig M, Baggs J (2020) Multidrug-resistant bacterial infections in U.S. hospitalized patients, 2012-2017. N Engl J Med 382(14):1309–1319. https://doi.org/10.1056/NEJMoa1914433
Jiang F, Waterfield NR, Yang J, Yang G, ** Q (2014) A Pseudomonas aeruginosa type VI secretion phospholipase D effector targets both prokaryotic and eukaryotic cells. Cell Host Microbe 15(5):600–610. https://doi.org/10.1016/j.chom.2014.04.010
Jousset A (2012) Ecological and evolutive implications of bacterial defences against predators. Environ Microbiol 14(8):1830–1843. https://doi.org/10.1111/j.1462-2920.2011.02627.x
Juan C, Peña C, Oliver A (2017) Host and pathogen biomarkers for severe Pseudomonas aeruginosa infections. J Infect Dis 215(suppl_1):S44–S51. https://doi.org/10.1093/infdis/jiw299
Khaledi A, Weimann A, Schniederjans M, Asgari E, Kuo TH, Oliver A, Cabot G, Kola A, Gastmeier P, Hogardt M, Jonas D, Mofrad MR, Bremges A, McHardy AC, Häussler S (2020) Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning-enabled molecular diagnostics. EMBO Mol Med 12(3):e10264. https://doi.org/10.15252/emmm.201910264
Khan NH, Ahsan M, Yoshizawa S, Hosoya S, Yokota A, Kogure K (2008) Multilocus sequence ty** and phylogenetic analyses of Pseudomonas aeruginosa isolates from the ocean. Appl Environ Microbiol 74(20):6194–6205. https://doi.org/10.1128/AEM.02322-07
Khanolkar RA, Clark ST, Wang PW, Hwang DM, Yau YCW, Waters VJ, Guttman DS (2020) Ecological succession of polymicrobial communities in the cystic fibrosis airways. mSystems 5(6):e00809–e00820. https://doi.org/10.1128/mSystems.00809-20
Kidd TJ, Ramsay KA, Hu H, Marks GB, Wainwright CE, Bye PT, Elkins MR, Robinson PJ, Rose BR, Wilson JW, Grimwood K, Bell SC, ACPinCF Investigator Group (2013) Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres. Eur Respir J 41(5):1091–1100. https://doi.org/10.1183/09031936.00060512
Kim M, Weigand MR, Oh S, Hatt JK, Krishnan R, Tezel U, Pavlostathis SG, Konstantinidis KT (2018) Widely used benzalkonium chloride disinfectants can promote antibiotic resistance. Appl Environ Microbiol 84(17):e01201–e01218. https://doi.org/10.1128/AEM.01201-18
Klockgether J, Tümmler B (2017) Recent advances in understanding Pseudomonas aeruginosa as a pathogen. F1000Res 6(1261). https://doi.org/10.12688/f1000research.10506.1
Klockgether J, Würdemann D, Reva O, Wiehlmann L, Tümmler B (2007) Diversity of the abundant pKLC102/PAGI-2 family of genomic islands in Pseudomonas aeruginosa. J Bacteriol 189:2443–2459
Klockgether J, Munder A, Neugebauer J, Davenport CF, Stanke F, Larbig KD, Heeb S, Schöck U, Pohl TM, Wiehlmann L, Tümmler B (2010) Genome diversity of Pseudomonas aeruginosa PAO1 laboratory strains. J Bacteriol 192(4):1113–1121. https://doi.org/10.1128/JB.01515-09
Klockgether J, Cramer N, Wiehlmann L, Davenport CF, Tümmler B (2011) Pseudomonas aeruginosa genomic structure and diversity. Front Microbiol 2:150. https://doi.org/10.3389/fmicb.2011.00150
Klockgether J, Miethke N, Kubesch P, Bohn YS, Brockhausen I, Cramer N, Eberl L, Greipel J, Herrmann C, Herrmann S, Horatzek S, Lingner M, Luciano L, Salunkhe P, Schomburg D, Wehsling M, Wiehlmann L, Davenport CF, Tümmler B (2013) Intraclonal diversity of the Pseudomonas aeruginosa cystic fibrosis airway isolates TBCF10839 and TBCF121838: distinct signatures of transcriptome, proteome, metabolome, adherence and pathogenicity despite an almost identical genome sequence. Environ Microbiol 15(1):191–210. https://doi.org/10.1111/j.1462-2920.2012.02842.x
Klockgether J, Cramer N, Fischer S, Wiehlmann L, Tümmler B (2018) Long-term microevolution of Pseudomonas aeruginosa differs between mildly and severely affected cystic fibrosis lungs. Am J Respir Cell Mol Biol 59(2):246–256. https://doi.org/10.1165/rcmb.2017-0356OC
Köhler T, Buckling A, van Delden C (2009) Cooperation and virulence of clinical Pseudomonas aeruginosa populations. Proc Natl Acad Sci U S A 106(15):6339–6344. https://doi.org/10.1073/pnas.0811741106
Konstantinidis KT, Tiedje JM (2005a) Towards a genome-based taxonomy for prokaryotes. J Bacteriol 187(18):6258–6264. https://doi.org/10.1128/JB.187.18.6258-6264.2005
Konstantinidis KT, Tiedje JM (2005b) Genomic insights that advance the species definition for prokaryotes. Proc Natl Acad Sci U S A 102(7):2567–2572. https://doi.org/10.1073/pnas.0409727102
Kordes A, Grahl N, Koska M, Preusse M, Arce-Rodriguez A, Abraham WR, Kaever V, Häussler S (2019a) Establishment of an induced memory response in Pseudomonas aeruginosa during infection of a eukaryotic host. ISME J 13(8):2018–2030. https://doi.org/10.1038/s41396-019-0412-1
Kordes A, Preusse M, Willger SD, Braubach P, Jonigk D, Haverich A, Warnecke G, Häussler S (2019b) Genetically diverse Pseudomonas aeruginosa populations display similar transcriptomic profiles in a cystic fibrosis explanted lung. Nat Commun 10(1):3397. https://doi.org/10.1038/s41467-019-11414-3
Kumar A, Munder A, Aravind R, Eapen SJ, Tümmler B, Raaijmakers JM (2013) Friend or foe: genetic and functional characterization of plant endophytic Pseudomonas aeruginosa. Environ Microbiol 15(3):764–779. https://doi.org/10.1111/1462-2920.12031
Kung VL, Ozer EA, Hauser AR (2010) The accessory genome of Pseudomonas aeruginosa. Microbiol Mol Biol Rev 74(4):621–641. https://doi.org/10.1128/MMBR.00027-10
La Rosa R, Rossi E, Feist AM, Johansen HK, Molin S (2021) Compensatory evolution of Pseudomonas aeruginosa’s slow growth phenotype suggests mechanisms of adaptation in cystic fibrosis. Nat Commun 12(1):3186. https://doi.org/10.1038/s41467-021-23451-y
Lee DG, Urbach JM, Wu G, Liberati NT, Feinbaum RL, Miyata S, Diggins LT, He J, Saucier M, Déziel E, Friedman L, Li L, Grills G, Montgomery K, Kucherlapati R, Rahme LG, Ausubel FM (2006) Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol 7(10):R90. https://doi.org/10.1186/gb-2006-7-10-r90
Lee C, Klockgether J, Fischer S, Trcek J, Tümmler B, Römling U (2020) Why?—Successful Pseudomonas aeruginosa clones with a focus on clone C. FEMS Microbiol Rev 44(6):740–762. https://doi.org/10.1093/femsre/fuaa029
López-Causapé C, Cabot G, Del Barrio-Tofiño E, Oliver A (2018) The versatile mutational resistome of Pseudomonas aeruginosa. Front Microbiol 9:685. https://doi.org/10.3389/fmicb.2018.00685
Lupo A, Haenni M, Madec JY (2018) Antimicrobial resistance in Acinetobacter spp. and Pseudomonas spp. Microbiol Spectr 6(3)
Mancl JM, Suarez C, Liang WG, Kovar DR, Tang WJ (2020) Pseudomonas aeruginosa exoenzyme Y directly bundles actin filaments. J Biol Chem 295(11):3506–3517. https://doi.org/10.1074/jbc.RA119.012320
Marvig RL, Johansen HK, Molin S, Jelsbak L (2013) Genome analysis of a transmissible lineage of Pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators. PLoS Genet 9(9):e1003741. https://doi.org/10.1371/journal.pgen.1003741
Marvig RL, Sommer LM, Molin S, Johansen HK (2015) Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis. Nat Genet 47(1):57–64. https://doi.org/10.1038/ng.3148
Mathee K (2018) Forensic investigation into the origin of Pseudomonas aeruginosa PA14—old but not lost. J Med Microbiol 67(8):1019–1021. https://doi.org/10.1099/jmm.0.000778
Maunders EA, Triniman RC, Western J, Rahman T, Welch M (2020) Global reprogramming of virulence and antibiotic resistance in Pseudomonas aeruginosa by a single nucleotide polymorphism in elongation factor, fusA1. J Biol Chem 295(48):16411–16426. https://doi.org/10.1074/jbc.RA119.012102
Melnik AV, Vázquez-Baeza Y, Aksenov AA, Hyde E, McAvoy AC, Wang M, da Silva RR, Protsyuk I, Wu JV, Bouslimani A, Lim YW, Luzzatto-Knaan T, Comstock W, Quinn RA, Wong R, Humphrey G, Ackermann G, Spivey T, Brouha SS, Bandeira N, Lin GY, Rohwer F, Conrad DJ, Alexandrov T, Knight R, Dorrestein PC, Garg N (2019) Molecular and microbial microenvironments in chronically diseased lungs associated with cystic fibrosis. mSystems 4(5):e00375–e00319. https://doi.org/10.1128/mSystems.00375-19
Moloney EM, Deasy EC, Swan JS, Brennan GI, O’Donnell MJ, Coleman DC (2020) Whole-genome sequencing identifies highly related Pseudomonas aeruginosa strains in multiple washbasin U-bends at several locations in one hospital: evidence for trafficking of potential pathogens via wastewater pipes. J Hosp Infect 104(4):484–491. https://doi.org/10.1016/j.jhin.2019.11.005
Moore MP, Lamont IL, Williams D, Paterson S, Kukavica-Ibrulj I, Tucker NP, Kenna DTD, Turton JF, Jeukens J, Freschi L, Wee BA, Loman NJ, Holden S, Manzoor S, Hawkey P, Southern KW, Walshaw MJ, Levesque RC, Fothergill JL, Winstanley C (2021) Transmission, adaptation and geographical spread of the Pseudomonas aeruginosa Liverpool epidemic strain. Microb Genom 7(3):mgen000511. https://doi.org/10.1099/mgen.0.000511
Moyne O, Castelli F, Bicout DJ, Boccard J, Camara B, Cournoyer B, Faudry E, Terrier S, Hannani D, Huot-Marchand S, Léger C, Maurin M, Ngo TD, Plazy C, Quinn RA, Attree I, Fenaille F, Toussaint B, Le Gouëllec A (2021) Metabotypes of Pseudomonas aeruginosa correlate with antibiotic resistance, virulence and clinical outcome in cystic fibrosis chronic infections. Metabolites 11(2):63. https://doi.org/10.3390/metabo11020063
Mulcahy LR, Burns JL, Lory S, Lewis K (2010) Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol 192(23):6191–6199. https://doi.org/10.1128/JB.01651-09
Oliver A, Cantón R, Campo P, Baquero F, Blázquez J (2000) High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288(5469):1251–1254. https://doi.org/10.1126/science.288.5469.1251
Oliver A, Baquero F, Blázquez J (2002) The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants. Mol Microbiol 43(6):1641–1650. https://doi.org/10.1046/j.1365-2958.2002.02855.x
Oliver A, Mulet X, López-Causapé C, Juan C (2015) The increasing threat of Pseudomonas aeruginosa high-risk clones. Drug Resist Updat 21-22:41–59. https://doi.org/10.1016/j.drup.2015.08.002
Organisation for Economic Cooperation and Development (OECD) (1997) Consensus document on information used in the assessment of environmental applications involving Pseudomonas. https://www.oecd.org/env/ehs/biotrack/46815578.pdf
Parkins MD, Somayaji R, Waters VJ (2018) Epidemiology, biology, and impact of clonal Pseudomonas aeruginosa infections in cystic fibrosis. Clin Microbiol Rev 31(4):e00019–e00018. https://doi.org/10.1128/CMR.00019-18
Pellett S, Bigley DV, Grimes DJ (1983) Distribution of Pseudomonas aeruginosa in a riverine ecosystem. Appl Environ Microbiol 45:328–332
Pérez A, Gato E, Pérez-Llarena J, Fernández-Cuenca F, Gude MJ, Oviaño M, Pachón ME, Garnacho J, González V, Pascual Á, Cisneros JM, Bou G (2019) High incidence of MDR and XDR Pseudomonas aeruginosa isolates obtained from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial. J Antimicrob Chemother 74(5):1244–1252. https://doi.org/10.1093/jac/dkz030
Pier GB (1985) Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction. J Infect Dis 151(4):575–580. https://doi.org/10.1093/infdis/151.4.575
Pirnay JP, Matthijs S, Colak H, Chablain P, Bilocq F, Van Eldere J, De Vos D, Zizi M, Triest L, Cornelis P (2005) Global Pseudomonas aeruginosa biodiversity as reflected in a Belgian river. Environ Microbiol 7(7):969–980. https://doi.org/10.1111/j.1462-2920.2005.00776.x
Potron A, Poirel L, Nordmann P (2015) Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology. Int J Antimicrob Agents 45(6):568–585
Pust MM, Wiehlmann L, Davenport C, Rudolf I, Dittrich AM, Tümmler B (2020) The human respiratory tract microbial community structures in healthy and cystic fibrosis infants. npj Biofilms Microbiomes 6(1):61. https://doi.org/10.1038/s41522-020-00171-7
Puzniak L, DePestel DD, Yu K, Ye G, Gupta V (2021) Epidemiology and regional variation of nonsusceptible and multidrug-resistant Pseudomonas aeruginosa isolates from intensive versus non-intensive care units across multiple centers in the United States. Diagn Microbiol Infect Dis 99(2):115172. https://doi.org/10.1016/j.diagmicrobio.2020.115172
Qian Z, Hui P, Han L, Ling-Zhi Y, Bo-Shun Z, Jie Z, Wan-Li G, Nan W, Shi-** J, Zhi-**g X (2020) Serotypes and virulence genes of Pseudomonas aeruginosa isolated from mink and its pathogenicity in mink. Microb Pathog 139:103904. https://doi.org/10.1016/j.micpath.2019.103904
Qiu X, Gurkar AU, Lory S (2006) Interstrain transfer of the large pathogenicity island (PAPI-1) of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 103:19830–19835
Quinn RA, Whiteson K, Lim YW, Salamon P, Bailey B, Mienardi S, Sanchez SE, Blake D, Conrad D, Rohwer F (2015) A Winogradsky-based culture system shows an association between microbial fermentation and cystic fibrosis exacerbation. ISME J 9(4):1024–1038. https://doi.org/10.1038/ismej.2014.234
Quinn RA, Whiteson K, Lim YW, Zhao J, Conrad D, LiPuma JJ, Rohwer F, Widder S (2016) Ecological networking of cystic fibrosis lung infections. npj Biofilms Microbiomes 2:4. https://doi.org/10.1038/s41522-016-0002-1
Raghuvanshi R, Vasco K, Vázquez-Baeza Y, Jiang L, Morton JT, Li D, Gonzalez A, DeRight Goldasich L, Humphrey G, Ackermann G, Swafford AD, Conrad D, Knight R, Dorrestein PC, Quinn RA (2020) High-resolution longitudinal dynamics of the cystic fibrosis sputum microbiome and metabolome through antibiotic therapy. mSystems 5(3):e00292–e00220. https://doi.org/10.1128/mSystems.00292-20
Reboud E, Basso P, Maillard AP, Huber P, Attrée I (2017) Exolysin shapes the virulence of Pseudomonas aeruginosa clonal outliers. Toxins (Basel) 9(11):364. https://doi.org/10.3390/toxins9110364
Renema P, Kozhukhar N, Pastukh V, Spadafora D, Paudel SS, Tambe DT, Alexeyev M, Frank DW, Stevens T (2020) Exoenzyme Y induces extracellular active caspase-7 accumulation independent from apoptosis: modulation of transmissible cytotoxicity. Am J Physiol Lung Cell Mol Physiol 319(2):L380–L390. https://doi.org/10.1152/ajplung.00508.2019
Ringen LM, Drake CH (1952) A study of the incidence of Pseudomonas aeruginosa from various natural sources. J Bacteriol 64:841–845
Robak OH, Heimesaat MM, Kruglov AA, Prepens S, Ninnemann J, Gutbier B, Reppe K, Hochrein H, Suter M, Kirschning CJ, Marathe V, Buer J, Hornef MW, Schnare M, Schneider P, Witzenrath M, Bereswill S, Steinhoff U, Suttorp N, Sander LE, Chaput C, Opitz B (2018) Antibiotic treatment-induced secondary IgA deficiency enhances susceptibility to Pseudomonas aeruginosa pneumonia. J Clin Invest 128(8):3535–3545. https://doi.org/10.1172/JCI97065
Römling U, Wingender J, Müller H, Tümmler B (1994) A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Appl Environ Microbiol 60(6):1734–1738. https://doi.org/10.1128/aem.60.6.1734-1738.1994
Rossi E, Falcone M, Molin S, Johansen HK (2018) High-resolution in situ transcriptomics of Pseudomonas aeruginosa unveils genotype independent patho-phenotypes in cystic fibrosis lungs. Nat Commun 9(1):3459. https://doi.org/10.1038/s41467-018-05944-5
Rossi E, La Rosa R, Bartell JA, Marvig RL, Haagensen JAJ, Sommer LM, Molin S, Johansen HK (2021) Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis. Nat Rev Microbiol 19(5):331–342. https://doi.org/10.1038/s41579-020-00477-5
Russell AB, Hood RD, Bui NK, LeRoux M, Vollmer W, Mougous JD (2011) Type VI secretion delivers bacteriolytic effectors to target cells. Nature 475(7356):343–347. https://doi.org/10.1038/nature10244
Salacha R, Kovacić F, Brochier-Armanet C, Wilhelm S, Tommassen J, Filloux A, Voulhoux R, Bleves S (2010) The Pseudomonas aeruginosa patatin-like protein PlpD is the archetype of a novel Type V secretion system. Environ Microbiol 12(6):1498–1512. https://doi.org/10.1111/j.1462-2920.2010.02174.x
Schroth MN, Cho JJ, Green SK, Kominos SD, Microbiology Society Publishing (2018) Epidemiology of Pseudomonas aeruginosa in agricultural areas. J Med Microbiol 67(8):1191–1201. https://doi.org/10.1099/jmm.0.000758
Schulenburg H, Ewbank JJ (2007) The genetics of pathogen avoidance in Caenorhabditis elegans. Mol Microbiol 66(3):563–570. https://doi.org/10.1111/j.1365-2958.2007.05946.x
Schuster M, Lostroh CP, Ogi T, Greenberg EP (2003) Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis. J Bacteriol 185(7):2066–2079. https://doi.org/10.1128/JB.185.7.2066-2079.2003
Secor PR, Burgener EB, Kinnersley M, Jennings LK, Roman-Cruz V, Popescu M, Van Belleghem JD, Haddock N, Copeland C, Michaels LA, de Vries CR, Chen Q, Pourtois J, Wheeler TJ, Milla CE, Bollyky PL (2020) Pf bacteriophage and their impact on Pseudomonas virulence, mammalian immunity, and chronic infections. Front Immunol 11:244. https://doi.org/10.3389/fimmu.2020.00244
Selezska K, Kazmierczak M, Müsken M, Garbe J, Schobert M, Häussler S, Wiehlmann L, Rohde C, Sikorski J (2012) Pseudomonas aeruginosa population structure revisited under environmental focus: impact of water quality and phage pressure. Environ Microbiol 14(8):1952–1967. https://doi.org/10.1111/j.1462-2920.2012.02719.x
Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV (2000) Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406(6799):959–964. https://doi.org/10.1038/35023079
Tedersoo L, Albertsen M, Anslan S, Callahan B (2021) Perspectives and benefits of high-throughput long-read sequencing in microbial ecology. Appl Environ Microbiol. https://doi.org/10.1128/AEM.00626-21
Treepong P, Kos VN, Guyeux C, Blanc DS, Bertrand X, Valot B, Hocquet D (2018) Global emergence of the widespread Pseudomonas aeruginosa ST235 clone. Clin Microbiol Infect 24:258–266
Tümmler B (2020) Progress in understanding the molecular pathology and microbiology of cystic fibrosis. Lancet Respir Med 8(1):8–10. https://doi.org/10.1016/S2213-2600(19)30333-9
Valli RXE, Lyng M, Kirkpatrick CL (2020) There is no hiding if you Seq: recent breakthroughs in Pseudomonas aeruginosa research revealed by genomic and transcriptomic next-generation sequencing. J Med Microbiol 69(2):162–175. https://doi.org/10.1099/jmm.0.001135
Vareechon C, Zmina SE, Karmakar M, Pearlman E, Rietsch A (2017) Pseudomonas aeruginosa effector ExoS inhibits ROS production in human neutrophils. Cell Host Microbe 21(5):611–618.e5. https://doi.org/10.1016/j.chom.2017.04.001
Varin A, Valot B, Cholley P, Morel C, Thouverez M, Hocquet D, Bertrand X (2017) High prevalence and moderate diversity of Pseudomonas aeruginosa in the U-bends of high-risk units in hospital. Int J Hyg Environ Health 220(5):880–885. https://doi.org/10.1016/j.ijheh.2017.04.003
Vasquez-Rifo A, Veksler-Lublinsky I, Cheng Z, Ausubel FM, Ambros V (2019) The Pseudomonas aeruginosa accessory genome elements influence virulence towards Caenorhabditis elegans. Genome Biol 20(1):270. https://doi.org/10.1186/s13059-019-1890-1
Welp AL, Bomberger JM (2020) Bacterial community interactions during chronic respiratory disease. Front Cell Infect Microbiol 10:213. https://doi.org/10.3389/fcimb.2020.00213
Whiteson KL, Bailey B, Bergkessel M, Conrad D, Delhaes L, Felts B, Harris JK, Hunter R, Lim YW, Maughan H, Quinn R, Salamon P, Sullivan J, Wagner BD, Rainey PB (2014) The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography. Am J Respir Crit Care Med 189(11):1309–1315. https://doi.org/10.1164/rccm.201312-2129PP
Wiehlmann L, Wagner G, Cramer N, Siebert B, Gudowius P, Morales G, Köhler T, van Delden C, Weinel C, Slickers P, Tümmler B (2007) Population structure of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 104(19):8101–8106. https://doi.org/10.1073/pnas.0609213104
Wiehlmann L, Cramer N, Ulrich J, Hedtfeld S, Weissbrodt H, Tümmler B (2012) Effective prevention of Pseudomonas aeruginosa cross-infection at a cystic fibrosis centre—results of a 10-year prospective study. Int J Med Microbiol 302(2):69–77. https://doi.org/10.1016/j.ijmm.2011.11.001
Wiehlmann L, Cramer N, Tümmler B (2015) Habitat-associated skew of clone abundance in the Pseudomonas aeruginosa population. Environ Microbiol Rep 7(6):955–960. https://doi.org/10.1111/1758-2229.12340
Winstanley C, Langille MG, Fothergill JL, Kukavica-Ibrulj I, Paradis-Bleau C, Sanschagrin F, Thomson NR, Winsor GL, Quail MA, Lennard N, Bignell A, Clarke L, Seeger K, Saunders D, Harris D, Parkhill J, Hancock RE, Brinkman FS, Levesque RC (2009) Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa. Genome Res 19(1):12–23. https://doi.org/10.1101/gr.086082.108
Wood S, Goldufsky J, Shafikhani SH (2015a) Pseudomonas aeruginosa ExoT induces atypical anoikis apoptosis in target host cells by transforming Crk adaptor protein into a cytotoxin. PLoS Pathog 11(5):e1004934. https://doi.org/10.1371/journal.ppat.1004934
Wood SJ, Goldufsky JW, Bello D, Masood S, Shafikhani SH (2015b) Pseudomonas aeruginosa ExoT induces mitochondrial apoptosis in target host cells in a manner that depends on its GTPase-activating protein (GAP) domain activity. J Biol Chem 290(48):29063–29073. https://doi.org/10.1074/jbc.M115.689950
Worlitzsch D, Wolz C, Botzenhart K, Hansis M, Burgdörfer H, Ogle JW, Döring G (1989) Molecular epidemiology of Pseudomonas aeruginosa—urinary tract infections in paraplegic patients. Zentralbl Hyg Umweltmed 189(2):175–184
Wurtzel O, Yoder-Himes DR, Han K, Dandekar AA, Edelheit S, Greenberg EP, Sorek R, Lory S (2012) The single-nucleotide resolution transcriptome of Pseudomonas aeruginosa grown in body temperature. PLoS Pathog 8(9):e1002945. https://doi.org/10.1371/journal.ppat.1002945
Yung DBY, Sircombe KJ, Pletzer D (2021) Friends or enemies? The complicated relationship between Pseudomonas aeruginosa and Staphylococcus aureus. Mol Microbiol. https://doi.org/10.1111/mmi.14699
Zhao Y, Guo L, Li J, Fang B, Huang X (2018) Molecular epidemiology, antimicrobial susceptibility, and pulsed-field gel electrophoresis genoty** of Pseudomonas aeruginosa isolates from mink. Can J Vet Res 82(4):256–263
Zhao K, Li W, Li J, Ma T, Wang K, Yuan Y, Li JS, **e R, Huang T, Zhang Y, Zhou Y, Huang N, Wu W, Wang Z, Zhang J, Yue B, Zhou Z, Li J, Wei YQ, Zhang X, Zhou X (2019) TesG is a type I secretion effector of Pseudomonas aeruginosa that suppresses the host immune response during chronic infection. Nat Microbiol 4(3):459–469. https://doi.org/10.1038/s41564-018-0322-4
Acknowledgments
Current work in the author’s laboratory related to the biology of Pseudomonas is supported by the Deutsche Forschungsgemeinschaft (Grant Number: SFB900/3 – 158989968 – A2 & Z1 SFB 900). The author declares that he has no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Tümmler, B. (2022). What Makes Pseudomonas aeruginosa a Pathogen?. In: Filloux, A., Ramos, JL. (eds) Pseudomonas aeruginosa. Advances in Experimental Medicine and Biology, vol 1386. Springer, Cham. https://doi.org/10.1007/978-3-031-08491-1_10
Download citation
DOI: https://doi.org/10.1007/978-3-031-08491-1_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-08490-4
Online ISBN: 978-3-031-08491-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)